Seeking Alpha

Time for AbbVie to sharpen its pencil a fourth time

  • Borrowing a page from AstraZeneca's (AZN) playbook, Shire plc (SHPG) publishes its "Path to US$10B In Product Sales by 2020" as a clear message to AbbVie (ABBV) that it needs to substantially increase its offer if it wants the BOD to seriously consider it.
  • Shire emphasizes its accelerating top-line growth, enhanced profitability, rich pipeline and total shareholder returns as proof that current management is on the right track and that Shire's future is bright continuing as an independent company.
Comments (3)
  • alexcampbello
    , contributor
    Comments (218) | Send Message
    What is the exchange rate for british pound to us dollars? Thnx
    23 Jun, 08:22 AM Reply Like
  • JDoe20
    , contributor
    Comments (348) | Send Message
    About $1.70 - the last bid was $236.66 per US ADR.
    23 Jun, 10:29 AM Reply Like
  • R140362241
    , contributor
    Comments (4) | Send Message
    Go to google to find out
    23 Jun, 09:38 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: